Smoking or its cessation does not alter the susceptibility to in vitro LDL oxidation

European Journal of Clinical Investigation

Volumn 30, Issue 11, 2000, Pages 972-979

  Van Den Berkmortel, F W P J ^a   Demacker, P N M ^a   Wollersheim, H ^a   Thien, T ^a   Stalenhoef, A F H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cigarette smoking; LDL oxidation; Smoking cessation

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID OXIDATION; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION;

ADULT; BODY COMPOSITION; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LIPIDS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NICOTINE; OXIDANTS; OXIDATION-REDUCTION; RISK FACTORS; SMOKING; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0033663961     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00739.x     Document Type: Article

References (45)

1. Cigarette smoking and stroke in a cohort of US male physicians
2. Mortality in relation to smoking: 40 years observations on male British doctors
3. Role of oxidised low density lipoprotein in atherogenesis
4. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
5. HDL as a protective factor against coronary heart disease. The Framingham Study
6. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women
7. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
8. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
9. Combined effects of lipid peroxidation and antioxidant status on carotid aterosclerosis in a population aged 59-71 years: The EVA study
10. Cigarette smoking and serum lipid and lipoprotein concentrations: An analysis of published data
11. Smoking habits and lipoproteins in British women
12. Smoking and plasma lipoproteins in man: Effects on low density, lipoprotein cholesterol levels and high density lipoprotein subfraction distribution
13. Higher plasma lipid transfer protein activities and unfavourable Iipoprotein changes in cigarette-smoking men
14. High-density lipoprotein concentrations increase after stopping smoking
15. Effect of smoking cessation on lipoprotein A-I and lipoprotein A-I: A-II levels
16. Changes in cardiovascular risk profile during the cessation of smoking
17. Randomized controlled smoking cessation study: Transient increase in plasma high density, lipoprotein but no change in lipoprotein oxidation resistance
18. Effects of cessation of smoking on serum lipids and high density, lipoprotein-cholesterol
19. Oxidants in cigarette smoke: Radicals, hydrogen peroxide, peroxynitrate and peroxynitrite
20. Enhanced modifications of low-density lipoproteins (LDL) by endothelial cells from smokers: A possible mechanism of smoking-related atherosclerosis
21. Modulation of oxidant stress in vivo in chronic cigarette smokers
22. Increase in circulating products of lipid peroxidation (F- 2-isoprostanes) in smokers - Smoking as a cause of oxidative damage
23. Cigarette smoking renders LDL susceptible to peroxidative mocification and enhanced metabolism by macrophages
24. Low density, lipoprotein susceptibility, to in vitro oxidation in healthy smokers and nonsmokers
25. Supplementation with vitamin E but not betacarotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking
26. Smoking cessation increases the resistance of low-density lipoprotein to oxidation
27. Improved measurement of low-density susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein
28. Effect of sucrose/ -80 degrees C storage of plasma on between-site values of low-density lipoprotein susceptibility to copper-induced oxidation. GERBAP Section Lipoproteines. Groupe d'Evaluation et de Recherche des Biologistes de l'Assistance Publique
29. Protein measurement with the folin phenol reagent
30. Continuous monitoring of in vitro oxidation of human low density lipoprotein
31. The redox status of coenzyme Q10 in total LDL as an indicator of in vivo oxidative modification. Studies on subjects with familial combined hyperlipidemia
32. Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: Studies in vitamin E deficient subjects
33. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
34. Improved fluorometric determination of malonaldehyde
35. Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio
36. Evaluation of the dual-precipitation method by comparison with the ultracentrifugation method for measurement of lipoproteins in serum
37. Interactions between people's diet and their smoking habits: The dietary and nutritional survey of British adults
38. Smoking and mechanisms of cardiovascular control
39. Smoking cessation and severity of weight gain in a national cohort
40. Nicotine does not affect plasma lipoprotein concentrations in healthy men
41. Smoking cessation in hospitalized patients. Results of a randomized trial
42. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis
43. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
44. Is transdermal nicotine associated with cardiovascular risk?
45. High density lipoprotein concentrations after cessation of smoking: The importance of alterations in diet